title: Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation.
abstract: OBJECTIVE
  The object of the present study is to determine whether native (n) low-density lipoprotein (LDL) isolated from men with type II diabetes and abnormal endothelial function inhibits endothelium-dependent relaxation more than n-LDL isolated from nondiabetic control subjects.
  
  
  BACKGROUND
  Endothelium-dependent vasodilation is impaired in men with type II diabetes and this may result from qualitative rather than quantitative abnormalities of LDL.
  
  
  METHODS
  Forearm blood flow responses to brachial artery infusions of acetylcholine (endothelium-dependent vasodilator) and nitroprusside (endothelium-independent vasodilator) were measured in 10 men with uncomplicated type II diabetes and 10 nondiabetic men of similar age and with similar plasma concentrations of LDL cholesterol. Native LDL was isolated by discontinuous density gradient ultracentrifugation using EDTA to prevent oxidation. Preconstricted rabbit aortic ring bioassay was used to determine inhibitory properties of n-LDL on endothelium-dependent relaxation by measuring relaxation to acetylcholine (and nitroprusside) in the presence and absence of n-LDL.
  
  
  RESULTS
  Forearm blood flow responses to acetylcholine but not nitroprusside were significantly impaired (p < 0.01) in diabetic men compared with control subjects. Native LDL (10 and 100 microg protein/ml) from diabetic men inhibited relaxation to acetylcholine by 13.9 +/- 4.8% and 61.9 +/- 7.8% (mean inhibition for all doses +/- SE), respectively, whereas n-LDL from control subjects inhibited relaxation by 7.3 +/- 3.0% and 23.9 +/- 5.7% (p < 0.01 for a difference between diabetic and control n-LDL). Relaxation to nitroprusside was not significantly inhibited by n-LDL.
  
  
  CONCLUSIONS
  A qualitative abnormality of LDL may account for endothelial dysfunction in men with type II diabetes.
authors.affiliation: Department of Clinical Pharmacology, Centre for Cardiovascular Biology and Medicine, King's College, London, United Kingdom.
authors.forename: K L
authors.initials: KL
authors.lastname: McNeill
authors.forename: L
authors.initials: L
authors.lastname: Fontana
authors.forename: D L
authors.initials: DL
authors.lastname: Russell-Jones
authors.forename: I
authors.initials: I
authors.lastname: Rajman
authors.forename: J M
authors.initials: JM
authors.lastname: Ritter
authors.forename: P J
authors.initials: PJ
authors.lastname: Chowienczyk
mesh_terms: D000109:Acetylcholine; D000818:Animals; D008078:Cholesterol, LDL / Q000097:blood*; D046508:Culture Techniques; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005542:Forearm / Q000098:blood supply; D006801:Humans; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside; D011817:Rabbits; D014664:Vasodilation / Q000502:physiology*
chemical_list: D008078:Cholesterol, LDL; D009599:Nitroprusside; D000109:Acetylcholine